Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T

Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3956-3957. doi: 10.1007/s00259-022-05845-2.

Eline A M Ruigrok^{1

2}, Giulia Tamborino^{1

3}, Erik de Blois¹, Stefan J Roobol^{1

4}, Nicole Verkaik⁴, Marijke De Saint-Hubert³, Mark W Konijnenberg¹, Wytske M van Weerden², Marion de Jong¹, Julie Nonnekens^{5

6}

¹ Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
² Department of Experimental Urology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
³ Research in Dosimetric Application, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium.
⁴ Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
⁵ Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands. j.nonnekens@erasmusmc.nl.
⁶ Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands. j.nonnekens@erasmusmc.nl.

No abstract available

Publication types